Tempest Therapeutics Inc. sell Amped
Start price
13.07.21
/
0%
€22.60
Target price
13.07.22
-
Performance (%)
-38.05%
End price
23.07.21
€14.00
Summary
This prediction ended on 23.07.21 with a price of €14.00. Amped correctly predicted massive losses of -38.05% for Tempest Therapeutics Inc.. This prediction was marked as speculative and is excluded from Amped's performance statistics.Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Tempest Therapeutics Inc. | - | - | - | - |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% | 65.510% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% | 95.368% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% | 42.232% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% | 59.132% |
According to Amped what are the pros and cons of Tempest Therapeutics Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Standard Investments for future growth
Good culture
Future proof or reliable business model
Sustainability is important
Cons
High valuation
Few uniques
Below average Marketposition
Little known brand
Comments by Amped for this prediction
In the thread Tempest Therapeutics Inc. diskutieren
Sell Tempest Therapeutics Inc.
In the thread Trading Tempest Therapeutics Inc.
Stopped prediction by Amped for Tempest Therapeutics Inc.
Tempest Therapeutics Inc.
Start price
Target price
Perf. (%)
€14.00
23.07.21
23.07.21
-
23.07.22
23.07.22
-84.43%
24.07.22
24.07.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Standard Investments for future growth
High valuation
Tempest Therapeutics Inc.
Start price
Target price
Perf. (%)
€24.00
13.07.21
13.07.21
-
13.07.22
13.07.22
-5.85%
13.07.21
13.07.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Standard Investments for future growth
High valuation